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The purpose of this study was to determine the
effect of lipase given by mouth on serum lipids,
serum lipase and urinary lipase in patients with
psoriasis
Pancreatic secretion is under hormonal control.
Secretin, elaborated by the duodenal mucosa, in
response to acid chyme, is transported by the
blood stream to the pancreas, activating secretion
of pancreatic juice. Still another substance origi-
nating in the intestinal mucosa which affects
pancreatic function is pancreozymin. This hor-
mone is apparently restricted in its activity to
stimulation of pancreatic enzymes and does not
influence the actual volume of pancreatic juice.
Other pancreatic hormones include lipocaic and
insulin, products of the alpha and beta cells
respectively. It is possible that lipocaic is func-
tionally similar to pyridoxine hydrochloride.
The enzymes identified in pancreatic juice
include trypsin, chymotrypsin, carboxypeptidase,
amylopsin (amylase), steapsin (lipase) and chol-
esterol esterase. Some of these are secreted in the
form of precursors (zymogens) such as trypsinogen
and chyrnotrypsinogen, which on contact with
the intestinal mucosa are activated by some as
yet undetermined means.
In view of many reports of improvement of
patients with psoriasis following the administra-
tion of various pancreatic enzymatic fractions, (1)
including whole defatted pancreas itself, (2) it
was thought that more definitive information
might be obtained by administration of these
pancreatic fractions alone.
The first study was confined to the lipolytic
enzyme. Since pancreatic lipase (steapsin) re-
quires an alkaline medium for activity, a search
was made for a lipase active in an acid medium, as
it was considered desirable that lipolysis begin
in the stomach; and also in order to avoid any
destruction of the enzyme by hydrochloric acid. A
lipase consisting of a purified enzyme preparation
of microbial origin was selected which hydrolysed
fats and fatty acid esters according to the fol-
lowing scheme.
Lipid + (lipase) — mono- and
di-glycerides + fatty acids
Fatty acid esters + (lipase)
alcohol + fatty acids
Maximum activity is obtained between pH 5
and 7 and is checked by inactivation of the enzyme
by a shift of the pH to below 1.5 or to above 10.
This lipase does not require emulsification of lipids
prior to lipolysis but is capable of hydrolysing
from 20 to 25 times its weight of emulsified fat in
two and a half hours. It has almost no proteolytic
activity at pH 7.
Method
Nineteen subjects with active psoriasis were
selected.
Total cholesterol, cholesterol esters, phospho-
lipids, total lipids, cephalin flocculation, icterus
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index, thymol turbidity, serum lipase and urinary
lipase determinations were made before and
after one month's ingestion of the enzyme lipase.t
Two capsules, each containing 0.5 gm were taken
with meals three times a day for approximately
one month. The tests were then repeated. No
alteration was made in the subjects' diets.
Chart I shows a tabulation of the laboratory
tests used, with "normals." Chart II shows a
tabulation of results of these tests.
f These tests were performed by the York-
Regency Medical Laboratories, New York, N. Y.
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Total lipids
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lation
Thymol turbidity
* This study was subsidized by Spirt & Corn-
pany, Waterbury, Conn.
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CHART II
Effect of Oral Administration of Lipase
Comment
In 1954 one of us (2) reported on the use of
defatted hog pancreas in psoriasis with remissions
in 66.7% of patients. These remissions were not
apparent before medication and dietary restric-
tions had been adhered to for at least three
months, but they were sustained indefinitely by
the continued administration of defatted pan-
creas, and a diet high in unsaturated fatty acid,
magnesium, phosphorus and pyridoxine hydro-
chloride content, and low in saturated fatty acids.
Since a previous investigation (3) had demon-
strated that approximately 36% of patients with
psoriasis improve spontaneously over a two year
period, the 66.7% remission was considered signi-
ficant. The possible action of defatted hog pan-
creas enzymes at a tissue or cellular level which
cannot be determined by evaluation of blood
lipids should be considered. Likewise, the activity
of whole pancreas in the autosynthesis of niacin
must be considered. A study of xanthurenic acid
excretion is being done.
Conclusions
In the present study there was no demon-
strable change in the blood or urine lipase of
patients with psoriasis following administration
of lipase for one month. In addition a review of
the clinical history of all patients failed to disclose
any significant improvement of the dermatosis
presented by them at the beginning of the investi-
gation.
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* Result of test before administration of Lipase.
f Result of test after administration of Lipase.
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